GLA & Invisible International Lyme & Tick-borne Disease CME Webinar
Long COVID/Long Lyme Expert Clinician Panel
Other lectures available for credit in this program:
Long Lyme/Co-Infections and Long COVID | What do they have in common?
0.5 CME. This course provides a summary of similarities between clinical and biological manifestations of chronic Lyme disease and long COVID. It presents results of a published clinical trial on low dose naltrexone as an agent in long COVID.
Instructor
John Lambert, MD
Full Clinical Professor, University College Dublin School of Medicine
Consultant in Infectious Diseases and Genitourinary Medicine, Mater Misericordiae University Hospital
Description
This CME is intended to help clinicians draw a parallel between long COVID and long Lyme disease by understanding the clinical manifestations and potential treatment options. Content for this free course was compiled by a team of clinicians, and researchers potentially speeding up treatment decisions and saving lives.
Learning Objectives:
- Describe what we can learn from chronic Lyme and apply to long COVID
- Understand the potential role of chronic infection, autoimmunity and inflammation as it relates to patient symptoms
- Increase awareness of the options for treatment of long COVID
Neuropsychiatric Symptoms with Lyme Disease & Tick-borne Illness
0.75 CME. This course is intended to help clinicians be aware of the mental health needs and risks in patients with Lyme disease and educates on appropriate professional mental health referral, based on symptoms and clinical presentation. This concise, data-driven overview will help clinicians quickly access the latest evidence on Lyme disease persistence after standard treatments, useful in overturning the long-held belief that Lyme disease is always easy to treat and cure.
Instructor
Shannon Delaney, MD, MA
Assistant Professor, Department of Psychiatry,
Columbia University Irving Medical Center
Description
This course is intended to help clinicians be aware of the mental health needs and risks in patients with Lyme disease and educates on appropriate professional mental health referral, based on symptoms and clinical presentation. This concise, data-driven overview will help clinicians quickly access the latest evidence on Lyme disease persistence after standard treatments, useful in overturning the long-held belief that Lyme disease is always easy to treat and cure.
Learning Objectives:
- Monitor patients for mental health sequelae from Lyme disease
- Incorporate a mental health screening tool in practice
- Modify practice to refer to mental health clinicians
Accreditation Statement
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.